Cozē personalizes lenses with free-form technology

Article

Robertson Optical Laboratories has announced its newest designs of private-label, digitally surfaced, free-form progressives: Cozē ADL and Cozē Wrap.

Atlanta-Robertson Optical Laboratories has announced its newest designs of private-label, digitally surfaced, free-form progressive lenses: Cozē ADL and Cozē Wrap.  

Cozē advanced design lenses (ADL) use Robertson’s digital free-form method of grinding, and offer powers tailored to a patient’s unique frame angle, tilt or wrap, and wearing vertex, the company said. Using specialized technology, Robertson can use measurements provided by eye-care professionals to override default measures to produce a wrap frame for optimal edge-to-edge vision, the company said.

“Patients see better at distance, intermediate, and near zones with these lenses,” said Mike Fussell, sales and customer service manager of Robertson Optical Laboratories of Atlanta, GA “The Cozē ADL and Wrap are top-of-the-line products with unsurpassed optics that are specifically tailored to each individual’s Rx and frame.”

Cozē lenses can be ordered through all Robertson Optical locations in Loganville, GA; Columbia, SC; and Greenville, SC. These labs serve customers throughout the United States.

For more articles in this issue of InDispensable, click here.

Recent Videos
Jessilin Quint, OD, MBA, FAAO, and Selina McGee, OD, FAAO
Jessilin Quint, OD, MBA, FAAO, and Selina McGee, OD, FAAO
EyeCon Co-chair Oluwatosin U. Smith, MD talks passion for research and education in ophthalmology
Eyerie Academics cofounders discuss the organization's future and preparing optometric students
Selina McGee, OD, FAAO, and Jessilin Quint, OD, MBA, FAAO
Selina McGee, OD, FAAO, and Jessilin Quint, OD, MBA, FAAO
Selina McGee, OD, FAAO, and Jessilin Quint, OD, MBA, FAAO
Selina McGee, OD, FAAO, and Jessilin Quint, OD, MBA, FAAO
Sherrol A. Reynolds, OD, speaks about highlights from the 2024 NOA Convention
A. Philip Aitsebaomo, O.D., Ph.D. outlines his talk on treating patients with prosthetic eyes
© 2024 MJH Life Sciences

All rights reserved.